Optimization of a murine immunization model for study of PF4/heparin antibodies
- 21 April 2009
- journal article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 7 (5), 857-864
- https://doi.org/10.1111/j.1538-7836.2009.03330.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Platelet factor 4-heparin complexes trigger immune responses independently of the MyD88 pathwayBritish Journal of Haematology, 2008
- Determinants of PF4/heparin immunogenicityBlood, 2007
- Heparin-Induced ThrombocytopeniaThe New England Journal of Medicine, 2006
- Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosisThrombosis and Haemostasis, 2005
- Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopeniaBlood, 2005
- Differences in susceptibility to colonic stem cell somatic mutation in three strains of miceThe Journal of Pathology, 2001
- Use of Heparin during Cardiopulmonary Bypass in Patients with a History of Heparin-Induced ThrombocytopeniaThe New England Journal of Medicine, 2000
- The Regulation of Immunity to Leishmania MajorAnnual Review of Immunology, 1995
- Characterization of anti-acetylcholine receptor (AChR) antibodies from mice differing in susceptibility for experimental autoimmune myasthenia gravis (EAMG)Clinical and Experimental Immunology, 1993
- Genetics of the Antibody Response to Dextran in MiceScience, 1972